Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acelagraft
- Development stage
- Unknown
- Lead developer
- Celularity
- Administration
- Topical
01
Overview
Acelagraft is a decellularized dehydrated human amniotic membrane (DDHAM) bi-layer graft developed by Celularity Inc. (formerly Celgene Cellular Therapeutics). As a human cell, tissue, and cellular and tissue-based product (HCT/P) regulated under Section 361 of the Public Health Service Act, it is designed for the treatment of acute and chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers. The product consists of a biological scaffold rich in extracellular matrix (ECM) components such as collagen, fibronectin, laminin, glycosaminoglycans, and elastin. It functions by providing a structural environment that supports cellular infiltration and tissue regeneration, rather than through a specific pharmacological or molecular target.
- Brand names
- Acelagraft
- Other names
- Decellularized dehydrated human amniotic membraneDDHAM
Beyond the preview
Go deeper on Acelagraft.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acelagraft.